Dr. Timothy D. Struve, MD

  • Cincinnati, OH
  • Radiation oncologist
NPI1841582186PAC ID8527206226
Medicare services, 2024
765
Medicare patients, 2024
165
Part D claims, 2024
151
Publications
6
Clinical trials
3
Practice address
3188 Bellevue Ave, Cincinnati, OH 45219
Practice phone
Call (513) 584-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UC Medical Center

Cincinnati, Ohio

See all 6 affiliations

Find Dr. Struve's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Timothy D. Struve is a radiation oncologist in Cincinnati, Ohio

Dr. Struve practices at UC Medical Center in Cincinnati, Ohio.

Dr. Struve's NPI, 1841582186, was assigned on May 4, 2011. Dr. Struve graduated from University of Nevada School of Medicine in 2011. Dr. Struve holds Ohio license 35128906.

NPI and contact details
Medicare PAC ID
8527206226
NPI enumeration date
May 4, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(513) 584-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Timothy D. Struve practices at UC Medical Center in Cincinnati, Ohio

Dr. Struve's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

  • UC Medical Center
    3188 Bellevue Ave, Cincinnati, OH 45219 · Hamilton CountyPhone(513) 584-1000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Timothy D. Struve is affiliated with 4 sites of care and 2 medical groups

Dr. Struve's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Struve is also affiliated with University of Cincinnati Medical Center. The medical group on file is Cincinnati Children's. Dmand AI also links Dr. Struve to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Struve

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Timothy D. Struve's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Struve practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UC Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Struve practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Timothy D. Struve is one of 267 radiation oncologists in Ohio

Radiation oncology is Dr. Struve's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Struve is licensed in Ohio.

Specialties and state licenses

  • Radiation oncology, OhioPrimaryLicense 35128906 · taxonomy 2085R0001X

Radiation oncologists near Dr. Struve

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Timothy D. Struve billed Medicare for 765 services in 2024

CMS data shows 765 Medicare services from Dr. Struve across 11 procedure codes in 2024, for 165 Medicare patients. Medicare paid $57,229 for them.

Medicare services, 2024765
Medicare patients165
Paid by Medicare$57,229
Procedure codes11

Dr. Struve's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 2282024: 633178%
Office and hospital visits
2023: 1072024: 13223%

Where Dr. Struve's Medicare services took place, 2024

  • In an office547%
  • In a facility71193%

Dr. Struve compared with the Ohio median for radiation oncologists, 2024

  • Dr. Struve
  • Ohio median
Medicare services
765vs 1,12032% below
Medicare patients
165vs 1575% above
Part D claims
105vs 313.4 times

Medians across 262 radiation oncologists in Ohio with Dmand AI profiles that report each measure.

Dr. Struve's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Struve

Need commercial claims for Dr. Struve?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Struve and other radiation oncologists in Ohio.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Timothy D. Struve treated 165 Medicare patients in 2024, average age 73

CMS counts 165 Medicare patients who saw Dr. Struve in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Struve's median patient age at 67, with 29% women.

Medicare patients, 2024165
Average age73
Average risk score1.67
Also on Medicaid14%

Dr. Struve's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Struve's Medicare patients by sex, 2024

  • Women4427%
  • Men12173%

Chronic conditions among Dr. Struve's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol74%
  4. Arthritis46%
  5. Ischemic heart disease38%
  6. Diabetes36%
  7. Chronic kidney disease27%
  8. Mood disorders26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Struve's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women29%
  • Men70%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Timothy D. Struve wrote 151 Medicare Part D claims in 2024

In 2024, Dr. Struve wrote 151 Medicare Part D claims for 52 patients. 94% of them were for generic drugs. CMS names the drug for 105 of them, across 3 drugs with 11 or more claims each, at $1,156 in total drug cost. In 2023, CMS named 118 claims across 3 drugs.

Part D claims, 2024151
Drugs named by CMS3
Total drug cost$1,156
Part D patients52

Dr. Struve's Part D claims by kind of drug, 2024

  • Generic142 claims94%
  • Brand-name and other9 claims6%

Dr. Struve's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1182024: 10511%

Drugs named by CMS: 3 in 2024, 3 in 2023.

See all prescribing by Dr. Struve

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Timothy D. Struve scored 82 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Struve for performance year 2024, reported as part of a group. Dr. Struve accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Struve's MIPS scores, performance year 2024

  • 82of 100Final score
  • 66of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Struve by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Timothy D. Struve has 6 publications on record

Dmand AI links 6 papers to Dr. Struve, published from 2020 to 2023. 2021 was the busiest year, with 2. Dr. Struve's most frequent co-authors are John C. Breneman, MD, Luke E. Pater, MD and Rekha Tripathi Chaudhary, MD.

Papers6
Years published2020 to 2023

Dr. Struve's papers by year, 2020 to 2023

Dr. Struve's most frequent co-authors

Recent publications by Dr. Struve

See all 6 publications and co-authors

See who Dr. Struve researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Struve works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Timothy D. Struve has worked on 3 clinical trials

Dmand AI links Dr. Struve to 3 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Bone Neoplasms, Brain Neoplasms and Prostatic Neoplasms.

Clinical trials with Dr. Struve by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. NonePhase 2: no trials
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Struve's trials

  • Bone Neoplasms
  • Brain Neoplasms
  • Prostatic Neoplasms
  • Bone Diseases
  • Central Nervous System Neoplasms

Investigators on the most trials with Dr. Struve

Recent clinical trials with Dr. Struve

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Timothy D. Struve received $432 in industry payments from 2018 to 2025

CMS Open Payments shows 10 general payments to Dr. Struve from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Augmenix, Inc. paid the most, $145.

General payments to Dr. Struve by program year, 2018 to 2025

Companies that paid Dr. Struve the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Struve

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Timothy D. Struve graduated from University of Nevada School of Medicine

Dr. Struve graduated from University of Nevada School of Medicine in 2011.

  1. Medical schoolUniversity of Nevada School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Timothy D. Struve's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Timothy D. Struve

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Timothy D. Struve's NPI number?

Dr. Timothy D. Struve's NPI number is 1841582186. It was assigned on May 4, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Timothy D. Struve?

Dr. Timothy D. Struve is a radiation oncologist in Cincinnati, Ohio. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Timothy D. Struve practice?

Dr. Struve practices at 3188 Bellevue Ave, Cincinnati, OH 45219. Dr. Struve's primary practice is UC Medical Center in Cincinnati, Ohio. Dmand AI also links Dr. Struve to 1 hospital, 1 group practice or clinic and 1 medical group.

What is Dr. Timothy D. Struve's office phone number?

The practice phone on file for Dr. Struve is (513) 584-1000.

What is Dr. Timothy D. Struve's medical license number?

Dr. Struve holds Ohio license 35128906.

Which hospitals is Dr. Timothy D. Struve affiliated with?

Dr. Struve is affiliated with University of Cincinnati Medical Center. Dmand AI links Dr. Struve to 1 more hospital.

What medical group is Dr. Timothy D. Struve part of?

Dr. Struve is linked to Cincinnati Children's. Dmand AI links Dr. Struve to 1 more medical group.

Does Dr. Timothy D. Struve accept Medicare?

Yes. CMS data shows Dr. Struve billed Medicare for 765 services in 2024, and Dr. Struve accepts Medicare assignment.

What is Dr. Timothy D. Struve's MIPS score?

Dr. Struve's MIPS final score for performance year 2024 is 82 out of 100, reported as part of a group.

How many Medicare patients does Dr. Timothy D. Struve see?

CMS counts 165 Medicare patients who saw Dr. Struve in 2024, with an average age of 73.

Show 7 more questionsShow fewer questions

What services does Dr. Timothy D. Struve bill to Medicare?

In 2024, Dr. Struve's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and office visit, established patient (99213).

Where did Dr. Timothy D. Struve go to medical school?

Dr. Struve graduated from University of Nevada School of Medicine in 2011.

What drugs does Dr. Timothy D. Struve prescribe most?

In 2024 Medicare Part D data, Dr. Struve's most prescribed drugs by claims were Tamsulosin HCl, Oxybutynin Chloride ER and Levetiracetam.

Has Dr. Timothy D. Struve received payments from drug or device companies?

CMS Open Payments shows $432 in general payments to Dr. Struve from 9 companies from 2018 to 2025. The largest total came from Augmenix, Inc.

How long has Dr. Timothy D. Struve been practicing?

Dr. Struve graduated from medical school in 2011, 15 years ago.

Does Dr. Timothy D. Struve do research?

Dmand AI links 6 publications to Dr. Struve, published from 2020 to 2023. Dr. Struve has worked on 3 clinical trials.

Who does Dr. Timothy D. Struve publish with?

Dr. Struve's most frequent co-authors are John C. Breneman, MD (2 shared papers), Luke E. Pater, MD (2 shared papers) and Rekha Tripathi Chaudhary, MD (1 shared paper).

Selling to radiation oncology practices?

See radiation oncologists in Ohio by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)